Abstract
The last decades showed the worldwide tendency to finding consensus between diagnostics improvement and constant increase of cost of medical services in conditions of restricted financing. The aim of the article was to analyze the diagnostic value of p16 and Ki-67 biomarkers in diagnostics of precancerous diseases of cervix. Data of 80 patients with cervical dysplasia of varying degree who received excisional treatment were analyzed. It was shown that cytological study has a high sensitivity (79.17%) for the diagnosis of CIN 2-3, but low specificity (53.57%). The p16 immunocytochemical biomarker has a high sensitivity for the diagnosis of CIN 2 (0.92; 95% CI: 0.76-0.98) with good specificity (0.78; 95% CI: 0.67-0.82), for the diagnosis of CIN 3 both sensitivity (0.93; 95% CI: 0.82-0.98) and specificity (0.93; 95% CI: 0.82-0.98) is high. The immunocytochemical biomarker Ki-67 has a high sensitivity for CIN 2 (0.92; 95% CI: 0.65-0.99), but insufficient specificity (0.62; 95% CI: 0.54-0.64), for the diagnosis of CIN 3 the sensitivity is very high (0.96; 95% CI: 0.80-0.99) as well as specificity (0.78; 95% CI: 0.69-0.81). The combined use of p16 and Ki-67 biomarkers can significantly increase the diagnostic accuracy of the diagnosis of high-grade precancerous pathology of cervix and justify timely surgical intervention. Such an approach for the differential diagnosis of severe dysplasia, on the one hand, may contribute to a decrease in the risk of developing cervical cancer, and on the other hand, it will allow to avoid unnecessary operations and preserve reproductive function of women, reduce the economic costs of treatment.
Highlights
The p16 immunocytochemical biomarker has a high sensitivity for the diagnosis of CIN 2 (0.92; 95% CI: 0.76-0.98) with good specificity (0.78; 95% CI: 0.67-0.82), for the diagnosis of CIN 3 both sensitivity (0.93; 95% CI: 0.82-0.98) and specificity (0.93; 95% CI: 0.82-0.98) is high
The immunocytochemical biomarker Ki-67 has a high sensitivity for CIN 2 (0.92; 95% CI: 0.65-0.99), but insufficient specificity (0.62; 95% CI: 0.54-0.64), for the diagnosis of CIN 3 the sensitivity is very high (0.96; 95% CI: 0.80-0.99) as well as specificity (0.78; 95% CI: 0.69-0.81)
8. Zhang L, Dai Y, Chen J, et al Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCRreverse dot blot assays
Summary
Роль иммуноцитохимических биомаркеров в диагностике предраковой патологии шейки матки. Иммуноцитохимический биомаркер р16 имеет высокую чувствительность диагностики ЦИН 2 (0,92; 95% ДИ: 0,76-0,98) при хорошей специфичности (0,78; 95% ДИ: 0,67-0,82), для диагностики ЦИН 3 чувствительность (0,93; 95% ДИ: 0,82-0,98) и специфичность (0,93; 95% ДИ: 0,82-0,98) высокие. Иммуноцитохимический биомаркер Кi-67 имеет высокую чувствительность для ЦИН 2 (0,92; 95% ДИ: 0,65-0,99), но недостаточную специфичность (0,62; 95% ДИ: 0,54-0,64), для диагностики ЦИН 3 чувствительность очень высока (0,96; 95% ДИ: 0,80-0,99), как и специфичность (0,78; 95% ДИ: 0,69-0,81). Сочетанное использование биомаркеров р16 и Кi-67 может значительно повысить диагностическую точность диагностики тяжелой предраковой патологии шейки матки и обосновать проведение своевременного хирургического вмешательства. Такой подход для дифференциальной диагностики тяжелой дисплазии будет способствовать, с одной стороны, уменьшению риска развития рака шейки матки, а с другой – позволит избежать ненужных операций и сохранить репродуктивную функцию женщин при уменьшении экономических затрат на лечение
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.